Specialty products dominate innovative drug approvals — a trend that looks set to continue.

Novartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused on activities in Greece and other countries, for $347 million. Novartis ...

The latest Holista Colltech Limited [HCT] news, articles, data and analysis from The Australian Financial Review ...